Oklo (NYSE:OKLO) Stock Price Up 3.6% - What's Next?

Key Points

• Oklo shares rose 3.6% to about $30.10, but remain roughly 84% below their 52-week high and well under key moving averages amid concerns about commercialization, losses and funding needs.
• The Department of Energy selected Oklo’s Groves 2 Forge isotope-production project for advancement, potentially expanding the company into medical-isotope markets alongside its advanced nuclear power business.
• Oklo launched another $1 billion stock offering, providing development capital but increasing dilution. Analysts remain broadly positive, with a “Moderate Buy” consensus and an average price target of $82.44, though the company continues to face execution and revenue uncertainty.

Oklo Inc. (NYSE:OKLO - Get Free Report) was up 3.6% on Thursday. The company traded as high as $30.13 and last traded at $30.0990. Approximately 10,949,490 shares traded hands during trading, a decline of 2% from the average session volume of 11,195,510 shares. The stock had previously closed at $29.04.

Oklo News Roundup

Here are the key news stories impacting Oklo this week:

• Positive Sentiment: The U.S. Department of Energy selected Oklo to advance its Groves 2 Forge isotope-production facility under the Nuclear Energy Launch Pad initiative. The project could expand Oklo beyond electricity generation into medical isotopes used in cancer treatment and other high-value markets. Oklo Advances Isotope Production Facility Under DOE Nuclear Initiative
• Positive Sentiment: Google’s long-term commitment to purchase power from new Constellation Energy reactors highlights renewed corporate interest in reliable nuclear power. The broader demand trend could eventually benefit advanced-reactor developers such as Oklo, although it does not represent a direct Oklo contract. Google Signed a Deal for Existing Reactors
• Neutral Sentiment: Oklo’s planned long-term power agreements with major customers, including Meta, remain potential catalysts. However, the company is still in an early development phase, so revenue generation and project execution remain uncertain.
• Negative Sentiment: Oklo launched another $1 billion stock sale at a substantially lower share price than its prior financing round. The offering provides capital for development but increases the share count and adds to the dilution already absorbed by investors since the company went public. Oklo Launched Another $1 Billion Stock Sale
• Negative Sentiment: Rising 10-year Treasury yields are pressuring nuclear and other long-duration growth stocks because higher discount rates reduce the present value of expected future cash flows. Oklo and peer NuScale have been especially vulnerable after their earlier speculative rally. Nuclear Stocks Under Pressure as Treasury Yields Rise
• Negative Sentiment: The stock has fallen roughly 84% from its 52-week high and is trading well below its 50-day and 200-day moving averages. The decline reflects concerns about commercialization timelines, ongoing losses and the funding needed to build its reactor and isotope businesses. Oklo Stock Hits a New 52-Week Low
• Negative Sentiment: General Counsel Vivek Narayanadas sold a small number of shares under a pre-arranged Rule 10b5-1 plan to cover tax withholding on vested equity awards. The transaction is not strong evidence of weakening insider confidence, but it adds modestly to negative sentiment. Oklo Insider Trading Activity

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. Guggenheim started coverage on shares of Oklo in a research report on Thursday, June 25th. They set a "neutral" rating on the stock. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Oklo in a research report on Friday, August 7th. UBS Group dropped their price objective on shares of Oklo from $55.00 to $41.00 and set a "neutral" rating on the stock in a research note on Friday, September 25th. HC Wainwright reiterated a "buy" rating and set a $90.00 price objective on shares of Oklo in a research note on Monday, August 10th. Finally, Canaccord Genuity Group cut their price objective on shares of Oklo from $125.00 to $100.00 and set a "buy" rating on the stock in a report on Monday, August 10th. One research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $82.44.

Oklo Price Performance

The business has a 50-day moving average of $39.60 and a two-hundred day moving average of $50.68. The company has a market cap of $5.60 billion, a P/E ratio of -32.02 and a beta of 1.20.

Oklo (NYSE:OKLO - Get Free Report) last announced its earnings results on Friday, August 7th. The company reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.16) by ($0.12). The business had revenue of $1.21 million for the quarter, compared to analyst estimates of $0.09 million. During the same period in the previous year, the company earned ($0.18) EPS. The business's quarterly revenue was up 11900.0% compared to the same quarter last year. Equities analysts anticipate that Oklo Inc. will post -1.02 EPS for the current fiscal year.

Insider Activity

In other news, Director John M. Jansen sold 6,354 shares of the company's stock in a transaction on Monday, September 14th. The stock was sold at an average price of $36.67, for a total transaction of $233,001.18. Following the transaction, the director directly owned 6,000 shares of the company's stock, valued at approximately $220,020. This represents a 51.43% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Richard Bealmear sold 16,430 shares of the business's stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $38.76, for a total value of $636,826.80. Following the transaction, the chief financial officer owned 455,976 shares in the company, valued at approximately $17,673,629.76. This trade represents a 3.48% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 287,994 shares of company stock worth $10,863,590 over the last 90 days. 12.70% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Oklo

Several institutional investors have recently added to or reduced their stakes in the business. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new position in Oklo during the 3rd quarter worth approximately $238,000. Accel Wealth Management acquired a new stake in Oklo during the 3rd quarter valued at approximately $224,000. Thor Investment Management Inc. OH ADV purchased a new stake in shares of Oklo in the 3rd quarter valued at $381,000. GK Wealth Management LLC purchased a new stake in shares of Oklo in the 3rd quarter valued at $69,000. Finally, Polaris Financial Partners acquired a new stake in shares of Oklo in the third quarter worth $93,000. Institutional investors and hedge funds own 85.03% of the company's stock.

Oklo Company Profile

Oklo Inc is an advanced fission technology company developing compact nuclear power plants designed to provide reliable, carbon-free electricity. Its flagship Aurora powerhouse is a small-scale fission system intended to operate for extended periods and supply power directly to industrial, commercial, and other large energy users.

The company is also developing fuel-recycling capabilities to support the use of recovered nuclear fuel in advanced reactors. Oklo has pursued partnerships and regulatory work in the United States, including activities associated with the Idaho National Laboratory, and is initially focused on serving U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.